Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 21, 2003Pediatric Transplantation

Treatment of monomorphic B‐cell lymphoma with rituximab after liver transplantation in a child

View Full Paper
Ask AI
Bookmark
Share

Authors

JBJavier BuenoHospital Universitari i Politècnic La FeCRCarmen RamilASAmelia Sánchez-GalindoHospital General Universitario Gregorio Marañón

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bueno et al. (2003) studied this question.

synapsesocial.com/papers/6a7ff1f4c48c717e4dee9fb9https://doi.org/10.1034/j.1399-3046.2003.00024.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.1998 · 2,771 citations
  2. 2AN INCREASED INCIDENCE OF EPSTEIN-BARR VIRUS INFECTION AND LYMPHOPROLIFERATIVE DISORDER IN YOUNG CHILDREN ON FK506 AFTER LIVER TRANSPLANTATION11995 · 273 citations
  3. 3INDICATIONS AND RESULTS OF CHEMOTHERAPY IN CHILDREN WITH POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE AFTER LIVER TRANSPLANTATION12000 · 64 citations
  4. 4TREATMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER WITH THE ANTI-CD20 MONOCLONAL ANTIBODY RITUXIMAB ALONE IN AN ADULT AFTER LIVER TRANSPLANTATION2000 · 61 citations
  5. 5POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANTATION1996 · 280 citations